Earnings ·
Codexis reported second quarter 2026 financial results with total revenues of $14.9 million, a slight decrease from…
CDXSCodexis, Inc.
Codexis reported second quarter 2026 financial results with total revenues of $14.9 million, a slight decrease from $15.3 million in the prior year period. The company completed an equity financing in July raising approximately $25 million in net proceeds, bringing proforma cash to roughly $80 million. Net loss for the quarter was $12.0 million, or $0.13 per share, compared to a $13.3 million loss in Q2 2025. The company reiterated its full-year 2026 revenue guidance of $72 million to $76 million and expects existing cash resources to fund operations through the end of 2028. Codexis operates in the biotechnology industry, providing enzymatic solutions for the manufacturing of complex therapeutics.